Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In the closing of the recent trading day, Veeva Systems (VEEV) stood at $275.89, denoting a -2.04% move from the preceding trading day.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.
Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.
Veeva Systems is executing strongly, with accelerating growth in Vault CRM migrations and robust momentum across its portfolio, supporting my continued buy rating. Crossix is a standout growth driver, expanding rapidly and delivering measurable ROI for customers, making it a high-priority investment for pharma clients. Veeva's targeted AI strategy, embedding AI agents into core workflows, positions the company for deeper integration and future monetization opportunities.
Veeva Systems (VEEV) reached $281 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.